L. Mary Smith

Insider Reports History

Location
Stamford, CT
Signature
/s/ Francis I. Perier, Jr. as Attorney-in Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by L. Mary Smith:

Company Role Class Num Shares Value Price $ Report Date Ownership
SpringWorks Therapeutics, Inc. Chief Development Officer Common Stock 233,363 $9,691,565 $41.53 08 Jan 2024 Direct
SpringWorks Therapeutics, Inc. Chief Development Officer Stock Option (Right to Buy) 60,000 04 Jan 2024 Direct

Insider Reports Filed by L. Mary Smith

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SWTX SpringWorks Therapeutics, Inc. 04 Jan 2024 4 -$230,207 4 Chief Development Officer 08 Jan 2024, 21:13
SWTX SpringWorks Therapeutics, Inc. 30 Jun 2023 1 $0 4 Chief Development Officer 05 Jul 2023, 16:06
SWTX SpringWorks Therapeutics, Inc. 07 Jan 2023 1 -$28,206 4 Chief Development Officer 10 Jan 2023, 15:01
SWTX SpringWorks Therapeutics, Inc. 05 Jan 2023 4 -$67,479 4 Chief Development Officer 09 Jan 2023, 16:00
SWTX SpringWorks Therapeutics, Inc. 18 Jul 2022 1 -$44,157 4 Chief Development Officer 20 Jul 2022, 18:02
SWTX SpringWorks Therapeutics, Inc. 30 Jun 2022 1 $0 4 Chief Development Officer 05 Jul 2022, 17:30
SWTX SpringWorks Therapeutics, Inc. 07 Jan 2022 1 -$66,207 4/A Chief Development Officer 14 Jan 2022, 15:58
SWTX SpringWorks Therapeutics, Inc. 06 Jan 2022 2 $0 4 Chief Development Officer 10 Jan 2022, 15:25
SWTX SpringWorks Therapeutics, Inc. 13 Oct 2021 3 -$536,675 4 Chief Development Officer 13 Oct 2021, 20:24
SWTX SpringWorks Therapeutics, Inc. 13 Jul 2021 3 -$785,777 4 Chief Development Officer 14 Jul 2021, 16:28